The strategy of laparoscopic surgery for asymptomatic antenatally diagnosed choledochal cyst.


Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
18 Jul 2023
Historique:
received: 24 05 2023
accepted: 28 06 2023
medline: 21 7 2023
pubmed: 19 7 2023
entrez: 18 7 2023
Statut: epublish

Résumé

The aim was to investigate the characteristics, surgical management, and outcomes of asymptomatic patients with antenatally diagnosed choledochal cysts (ADCCs) and to justify the strategy of laparoscopic surgery (LS) for them in our hospital. We developed our LS strategy for asymptomatic ADCCs. Patients with asymptomatic ADCCs who underwent LS or open surgery (OS) during January 2010 and January 2020 were included. Patients with recorded symptomatic ADCCs were exclude. All data of group LS and group OS were statistically compared and analyzed. Twenty-five patients received LS and 18 patients received OS were included. There was no significant difference in baseline characteristics between the groups. A total of 65.1% of biliary sludge formation was detected preoperatively by ultrasonography (US) (72.0% in group LS, 55.6% in group OS, P = 0.26). Compared to the OS group, the LS group had a longer operative time (313.4 ± 27.2 vs. 154.0 ± 11.9 min, P = 0.02), shorter postoperative fasting period (3.1 ± 1.2 vs. 6.2 ± 2.3 days, P = 0.03), and shorter postoperative hospital stay (5.1 ± 1.9 vs. 9.2 ± 1.1 days, P = 0.03). The incidence of late complications, such as reflux cholangitis, adhesive intestinal obstruction, and biliary enteric anastomotic stricture with stone formation, was not significantly different between the two groups. The liver function and liver stiffness of all patients in the two groups were normal. Based on the strategy for asymptomatic ADCCs in our hospital, the perioperative safety and midterm follow-up results after LS were satisfactory and comparable to those after OS.

Sections du résumé

BACKGROUND BACKGROUND
The aim was to investigate the characteristics, surgical management, and outcomes of asymptomatic patients with antenatally diagnosed choledochal cysts (ADCCs) and to justify the strategy of laparoscopic surgery (LS) for them in our hospital.
METHODS METHODS
We developed our LS strategy for asymptomatic ADCCs. Patients with asymptomatic ADCCs who underwent LS or open surgery (OS) during January 2010 and January 2020 were included. Patients with recorded symptomatic ADCCs were exclude. All data of group LS and group OS were statistically compared and analyzed.
RESULTS RESULTS
Twenty-five patients received LS and 18 patients received OS were included. There was no significant difference in baseline characteristics between the groups. A total of 65.1% of biliary sludge formation was detected preoperatively by ultrasonography (US) (72.0% in group LS, 55.6% in group OS, P = 0.26). Compared to the OS group, the LS group had a longer operative time (313.4 ± 27.2 vs. 154.0 ± 11.9 min, P = 0.02), shorter postoperative fasting period (3.1 ± 1.2 vs. 6.2 ± 2.3 days, P = 0.03), and shorter postoperative hospital stay (5.1 ± 1.9 vs. 9.2 ± 1.1 days, P = 0.03). The incidence of late complications, such as reflux cholangitis, adhesive intestinal obstruction, and biliary enteric anastomotic stricture with stone formation, was not significantly different between the two groups. The liver function and liver stiffness of all patients in the two groups were normal.
CONCLUSIONS CONCLUSIONS
Based on the strategy for asymptomatic ADCCs in our hospital, the perioperative safety and midterm follow-up results after LS were satisfactory and comparable to those after OS.

Identifiants

pubmed: 37464354
doi: 10.1186/s12893-023-02095-3
pii: 10.1186/s12893-023-02095-3
pmc: PMC10354969
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

204

Subventions

Organisme : National Natural Science Foundation of China
ID : 82273556
Organisme : Key Project in the Science & Technology Program of Sichuan Province
ID : 2022YFS0233
Organisme : Project of '0 to 1' of Sichuan University
ID : 2022SCUH0033
Organisme : Med-X Center for Informatics Funding Project
ID : YGJC004
Organisme : 1·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University
ID : 2019HXFH056
Organisme : 1·3·5 Project for Disciplines of Excellence-Clinical Research Interdisciplinary Innovation Project of West China Hospital of Sichuan University
ID : ZYJC21060

Informations de copyright

© 2023. The Author(s).

Références

Hum Pathol. 2006 Dec;37(12):1519-26
pubmed: 16997354
Pediatr Surg Int. 2008 Sep;24(9):1079-82
pubmed: 18682962
J Pediatr Surg. 1999 Dec;34(12):1765-8
pubmed: 10626850
Pediatr Surg Int. 1996 Mar;11(2-3):130-3
pubmed: 24057535
J Gastrointest Surg. 2008 May;12(5):822-8
pubmed: 18058186
Eur J Pediatr Surg. 2007 Feb;17(1):12-6
pubmed: 17407015
J Pediatr Surg. 2010 May;45(5):e11-4
pubmed: 20438907
J Pediatr Surg. 1983 Aug;18(4):387-93
pubmed: 6620079
Dig Surg. 2010;27(6):492-501
pubmed: 21063126
Surg Today. 2016 Dec;46(12):1410-1414
pubmed: 26935547
Surg Laparosc Endosc. 1996 Aug;6(4):315-7
pubmed: 8840457
J Pediatr Surg. 2012 Mar;47(3):506-12
pubmed: 22424346
Br J Radiol. 1980 Sep;53(633):906-7
pubmed: 7437717
J Pediatr Surg. 2017 Jul;52(7):1156-1160
pubmed: 28318597
J Pediatr Surg. 2011 Aug;46(8):1503-9
pubmed: 21843715
J Pediatr Surg. 2012 Dec;47(12):2175-8
pubmed: 23217871
J Hepatobiliary Pancreat Sci. 2018 Dec;25(12):544-549
pubmed: 30328288
Arch Surg. 1972 Mar;104(3):302-9
pubmed: 5010841
J Pediatr Surg. 2011 Dec;46(12):2296-300
pubmed: 22152868
Surg Endosc. 2016 Dec;30(12):5494-5499
pubmed: 27129540
J Gastrointest Surg. 2008 Dec;12(12):2191-5
pubmed: 18677540
Pediatr Surg Int. 2011 Aug;27(8):829-32
pubmed: 21431961
Surg Today. 2006;36(2):151-4
pubmed: 16440162
J Pediatr Surg. 1986 Feb;21(2):112-7
pubmed: 3512815
World J Surg. 2011 May;35(5):1094-102
pubmed: 21360306
J Gastroenterol. 2012 Jul;47(7):731-59
pubmed: 22722902
Am Surg. 2002 Sep;68(9):816-9
pubmed: 12356157
Surg Endosc. 2011 May;25(5):1567-73
pubmed: 21052722
Scand J Gastroenterol. 2010 Jun;45(6):739-45
pubmed: 20201620
Asian J Surg. 2003 Oct;26(4):213-7
pubmed: 14530107
J Pediatr Surg. 2006 Dec;41(12):1984-6
pubmed: 17161187
J Pediatr Surg. 1995 Mar;30(3):478-81
pubmed: 7760246

Auteurs

Xuepeng Zhang (X)

Department of Pediatric Surgery, West China Hospital, Sichuan University, #37 Guo- Xue-Xiang, Chengdu, 610041, China.
Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.

Jianli Jin (J)

Department of Pediatric Surgery, West China Hospital, Sichuan University, #37 Guo- Xue-Xiang, Chengdu, 610041, China.
West China School of Nursing/West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

Tong Qiu (T)

Department of Pediatric Surgery, West China Hospital, Sichuan University, #37 Guo- Xue-Xiang, Chengdu, 610041, China.

Jiangyuan Zhou (J)

Department of Pediatric Surgery, West China Hospital, Sichuan University, #37 Guo- Xue-Xiang, Chengdu, 610041, China.

Guowei Che (G)

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.

Yi Ji (Y)

Department of Pediatric Surgery, West China Hospital, Sichuan University, #37 Guo- Xue-Xiang, Chengdu, 610041, China. jijiyuanyuan@163.com.

Zhicheng Xu (Z)

Department of Pediatric Surgery, West China Hospital, Sichuan University, #37 Guo- Xue-Xiang, Chengdu, 610041, China. xzcxewk@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH